Agronomics Limited Appointment of Joint Corporate Broker (3706S)

TIDMANIC

RNS Number : 3706S

Agronomics Limited

14 July 2022

14(th) July 2022

Agronomics Limited

("Agronomics" or the "Company")

Appointment of Joint Corporate Broker

Agronomics Limited (AIM:ANIC), a leading listed company focused on cellular agriculture, is pleased to announce the appointment of Canaccord Genuity Limited ("Canaccord") as its Joint Corporate Broker with immediate effect.

For further information please contact:

 
       Agronomics            Beaumont          Canaccord            Cenkos         Peterhouse          TB Cardew 
         Limited              Cornish       Genuity Limited        Securities        Capital 
                              Limited                                 Plc            Limited 
      The Company             Nomad          Joint Broker        Joint Broker     Joint Broker     Public Relations 
                        ================  ===================  ===============  ===============  ===================== 
        Richard           Roland Cornish     Andrew Potts        Giles Balleny    Lucy Williams       Ed Orlebar 
          Reed             James Biddle        Harry Rees           Michael          Charles           Charlotte 
       Denham Eke                              Alex Aylen           Johnson         Goodfellow          Anderson 
                                           (Head of Equities) 
                        ================  ===================  ===============  ===============  ===================== 
                                                                                                      +44 (0) 20 
                                                                                                       7930 0777 
                                                                                                     +44 (0) 7738 
        +44 (0)              +44 (0)                                +44 (0)          +44 (0)            724 630 
       1624 639396            207 628         +44 (0) 207           207 397          207 469     agronomics@tbcardew.c 
   info@agronomics.im          3396             523 8000              8900             0936               om 
                        ================  ===================  ===============  ===============  =====================

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 22 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 4 billion has been invested worldwide since the industry's inception in 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCLXLFFLDLXBBZ

(END) Dow Jones Newswires

July 14, 2022 02:00 ET (06:00 GMT)

Agronomics (AQSE:ANIC.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024